This approach was first reported by Zangi et al., who showed that intramyocardial injection of mmRNA for vascular endothelial growth factor A (VEGF-A) improved cardiac function in mice with myocardial infarction[5]. The gene discussed is VEGFA; the disease is myocardial infarction.